ENAMINE LTD

ENAMINE LTD specializes in the synthesis and delivery of high-purity small-molecule chemical libraries for pharmaceutical research, with demonstrated expertise in GPCR-targeted compound libraries. The company produces precisely characterized chemical entities in powder and DMSO solution formats, adhering to stringent purity and consistency standards required for high-throughput screening and drug discovery workflows. Their technical capabilities include library design, parallel synthesis, analytical validation, and controlled material handling, supporting early-stage drug development for targets such as G protein-coupled receptors. ENAMINE’s differentiation lies in its ability to deliver large-scale, structurally diverse compound sets with reproducible physical and chemical properties, enabling robust biological assay performance. The contractor has delivered chemical research materials to the Department of Health and Human Services, indicating direct engagement with federal biomedical research initiatives. This relationship suggests alignment with NIH-funded programs or public health laboratories focused on target validation and lead compound identification. The nature of the work implies a trusted supplier role in supporting preclinical discovery pipelines within government-funded therapeutic research. ENAMINE’s primary industry focus is in miscellaneous chemical product manufacturing, specifically the production of research-grade chemical libraries for life sciences applications. This places them at the intersection of medicinal chemistry and biopharmaceutical R&D, serving clients engaged in target-based drug discovery. Their market positioning is niche but critical, providing essential building blocks for academic, government, and commercial drug development teams requiring validated screening compounds. ENAMINE LTD is a small business entity headquartered in Cincinnati, Ohio, with no federal certifications on record. The company operates as a specialized chemical supplier within the federal research ecosystem, leveraging its technical precision and controlled manufacturing processes to meet the rigorous demands of government-funded biomedical projects. Its geographic presence supports regional access to pharmaceutical and life sciences research hubs.